Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Cancer Research|2016Cited by 115
Abstract 4367: Discovery and evaluation of pharmacodynamic and predictive biomarkers for anti-RSPO3, a treatment that reduces tumor growth and cancer stem cell frequency in patient derived xenograft tumor modelsFiore Cattaruzza, Ann M. Kapoun, Wan-Ching Yen et al.|Cancer Research|2015Cited by 1
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0
Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Unknown|2023Cited by 0